ethyl 6-(t-butoxycarbonylamino)-5-phenylhexanoate | 111742-88-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 6-(t-butoxycarbonylamino)-5-phenylhexanoate
• 英文别名: ethyl 6-[(2-methylpropan-2-yl)oxycarbonylamino]-5-phenylhexanoate
• CAS: 111742-88-2
• 化学式: C₁₉H₂₉NO₄
• 分子量: 335.444
• InChiKey: NTKGPAYLLAJCAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  24
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 6-(t-butoxycarbonylamino)-5-phenylhexanoate 在 盐酸 、 sodium hydroxide 作用下， 以 水 、 乙酸乙酯 为溶剂， 生成 6-(t-butoxycarbonylamino)-5-phenylhexanoic acid
  参考文献：
  名称：

  Lactam derivatives and their use as hypotensive agents

  摘要：

  式(I)的化合物：##STR1##（其中R.sup.1和R.sup.3是有机基团，A是直接键，-CH.sub.2-，-CH.sub.2 CH.sub.2-，-CO-CH.sub.2-，-O-CH.sub.2-或-S-CH.sub.2-，B是低碳烷基，n为1-3）是有价值的降压剂，可以通过相应的具有3-位氨基的化合物的缩合反应制备。

  公开号：

  US04734410A1
• 作为产物：
  描述：

  4-溴丁酸乙酯 在 镍 氢气 、 sodium hydride 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 paraffin 为溶剂， 反应 7.5h， 生成 ethyl 6-(t-butoxycarbonylamino)-5-phenylhexanoate
  参考文献：
  名称：

  Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives

  摘要：

  alpha-[(3S)-3-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-6 or 7-phenylperhydroazepin-1-yl]acetic acids (monoester monoacids) and their dicarboxylic acids were synthesized, and their angiotensin-converting enzyme (ACE) inhibitory activities were evaluated. The dicarboxylic acids having phenyl substituents at the 6R, 6S, and 7S positions on the azepinone ring showed potent inhibition in vitro. The corresponding monoester monoacids, when administered orally, suppressed the pressor response to angiotensin I administered intravenously. The monoester monoacids having the phenyl substituent at the 6-position showed a longer duration of action than one having the substituent at the 7-position. The structure-activity relationship was studied on the basis of the conformational energy calculation.

  DOI：

  10.1021/jm00397a027

文献信息

• Lactam derivatives and their use as hypotensive agents
  申请人：Sankyo Company Limited

  公开号：US04734410A1

  公开（公告）日：1988-03-29

  Compounds of formula (I): ##STR1## (wherein R.sup.1 and R.sup.3 are organic groups, A is a direct bond, --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CO--CH.sub.2, --O--CH.sub.2 -- or --S--CH.sub.2 --, B is lower alkylene and n is 1-3) are valuable hypotensive agents which may be prepared by a condensation reaction of the corresponding compound having an amino group at the 3-position.

  式(I)的化合物：##STR1##（其中R.sup.1和R.sup.3是有机基团，A是直接键，-CH.sub.2-，-CH.sub.2 CH.sub.2-，-CO-CH.sub.2-，-O-CH.sub.2-或-S-CH.sub.2-，B是低碳烷基，n为1-3）是有价值的降压剂，可以通过相应的具有3-位氨基的化合物的缩合反应制备。
• YANAGISAWA, HIROAKI;ISHIHARA, SADAO;ANDO, AKIKO;KANAZAKI, TAKURO;MIYAMOTO+, J. MED. CHEM., 31,(1988) N 2, 422-428
  作者：YANAGISAWA, HIROAKI、ISHIHARA, SADAO、ANDO, AKIKO、KANAZAKI, TAKURO、MIYAMOTO+

  DOI：——

  日期：——
• Lactam derivatives, their preparation and their use as hypotensive agents
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0220865B1

  公开（公告）日：1992-07-29
• US4734410A
  申请人：——

  公开号：US4734410A

  公开（公告）日：1988-03-29
• Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives
  作者：Hiroaki Yanagisawa、Sadao Ishihara、Akiko Ando、Takuro Kanazaki、Shuichi Miyamoto、Hiroyuki Koike、Yasuteru Iijima、Kiyoshi Oizumi、Yoichi Matsushita、Tadashi Hata

  DOI：10.1021/jm00397a027

  日期：1988.2

  alpha-[(3S)-3-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-6 or 7-phenylperhydroazepin-1-yl]acetic acids (monoester monoacids) and their dicarboxylic acids were synthesized, and their angiotensin-converting enzyme (ACE) inhibitory activities were evaluated. The dicarboxylic acids having phenyl substituents at the 6R, 6S, and 7S positions on the azepinone ring showed potent inhibition in vitro. The corresponding monoester monoacids, when administered orally, suppressed the pressor response to angiotensin I administered intravenously. The monoester monoacids having the phenyl substituent at the 6-position showed a longer duration of action than one having the substituent at the 7-position. The structure-activity relationship was studied on the basis of the conformational energy calculation.